美国FDA药品数据库（U.S. FDA Drugs Database）
符合检索条件的记录共 33 条
共 2 页，当前第 2 页
| 商品名 |
申请号 |
产品号 |
申请类型 |
活性成分 |
剂型/给药途径 |
规格/剂量 |
RLD |
RS |
申请号原始批准/暂定批准日期 |
产品号批准日期 |
申请人 |
市场状态 |
| PIRFENIDONE |
212600 |
001 |
ANDA |
PIRFENIDONE |
CAPSULE;ORAL |
267MG |
No
|
No
|
2022/06/13
|
2022/06/13
|
SANDOZ INC |
Prescription |
| PIRFENIDONE |
212722 |
001 |
ANDA |
PIRFENIDONE |
TABLET;ORAL |
267MG |
No
|
No
|
2022/07/19
|
2022/07/19
|
LAURUS |
Prescription |
| PIRFENIDONE |
212722 |
002 |
ANDA |
PIRFENIDONE |
TABLET;ORAL |
534MG |
No
|
No
|
2022/07/19
|
2022/07/19
|
LAURUS |
Prescription |
| PIRFENIDONE |
212722 |
003 |
ANDA |
PIRFENIDONE |
TABLET;ORAL |
801MG |
No
|
No
|
2022/07/19
|
2022/07/19
|
LAURUS |
Prescription |
| PIRFENIDONE |
212724 |
001 |
ANDA |
PIRFENIDONE |
CAPSULE;ORAL |
267MG |
No
|
No
|
2022/07/19
|
2022/07/19
|
LAURUS |
Prescription |
| PIRFENIDONE |
212747 |
001 |
ANDA |
PIRFENIDONE |
TABLET;ORAL |
267MG |
No
|
No
|
2022/07/21
|
2022/07/21
|
AIZANT |
Prescription |
| PIRFENIDONE |
212747 |
002 |
ANDA |
PIRFENIDONE |
TABLET;ORAL |
534MG |
No
|
No
|
2022/07/21
|
2022/07/21
|
AIZANT |
Prescription |
| PIRFENIDONE |
212747 |
003 |
ANDA |
PIRFENIDONE |
TABLET;ORAL |
801MG |
No
|
No
|
2022/07/21
|
2022/07/21
|
AIZANT |
Prescription |
| PIRFENIDONE |
212077 |
001 |
ANDA |
PIRFENIDONE |
CAPSULE;ORAL |
267MG |
No
|
No
|
2022/08/01
|
2022/08/01
|
SCIEGEN PHARMS INC |
Prescription |
| PIRFENIDONE |
212078 |
001 |
ANDA |
PIRFENIDONE |
TABLET;ORAL |
267MG |
No
|
No
|
2022/08/01
|
2022/08/01
|
SCIEGEN PHARMS INC |
Prescription |
| PIRFENIDONE |
212078 |
002 |
ANDA |
PIRFENIDONE |
TABLET;ORAL |
801MG |
No
|
No
|
2022/08/01
|
2022/08/01
|
SCIEGEN PHARMS INC |
Prescription |
| PIRFENIDONE |
212674 |
001 |
ANDA |
PIRFENIDONE |
TABLET;ORAL |
267MG |
No
|
No
|
2022/09/21
|
2022/09/21
|
HETERO LABS LTD V |
Prescription |
| PIRFENIDONE |
212674 |
002 |
ANDA |
PIRFENIDONE |
TABLET;ORAL |
801MG |
No
|
No
|
2022/09/21
|
2022/09/21
|
HETERO LABS LTD V |
Prescription |